SCHEMBL7877966

SCHEMBL7877966

CN(C)Cc1ccc(COc2ccc(C(F)(F)F)c3cc(C(=O)N(C)C(=N)N)[nH]c23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.36
RXRA P19793 3/20 0.36
RXRB P28702 3/20 0.36
RXRG P48443 3/20 0.36
ROCK2 O75116 1/20 0.35
RHEB Q15382 1/20 0.34
NEK2 P51955 2/20 0.33
PLK1 P53350 2/20 0.33
AURKA O14965 1/20 0.33
CDK2 P24941 1/20 0.33
TTK P33981 1/20 0.33
FFAR1 O14842 2/20 0.32
FFAR4 Q5NUL3 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TRPM8 Q7Z2W7 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
S1PR4 O95977 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7881492 0.92 MRGPRX4 (0.37) S1PR1ROCK2NEK2PLK1FFAR4
SCHEMBL7879648 0.92 ACHE (0.35) S1PR1RXRARXRBRXRGROCK2
SCHEMBL7884316 0.92 S1PR1 (0.37) S1PR1RXRARXRBRXRGRHEB
Hydrochloric Acid SCHEMBL7873300 0.90 S1PR1 (0.40) S1PR1RXRARXRBRXRGFFAR1
SCHEMBL7878053 0.89 SLC6A4 (0.40) ROCK2RHEBFFAR1MEN1KMT2A
SCHEMBL7877781 0.88 RHEB (0.41) RXRARXRBRXRGRHEBMEN1
SCHEMBL7877440 0.88 S1PR1 (0.34) S1PR1RXRARXRBRXRGRHEB
SCHEMBL7878060 0.87 FFAR1 (0.37) S1PR1NEK2PLK1AURKACDK2
Hydrochloric Acid SCHEMBL7881045 0.87 RHEB (0.41) RHEBMEN1KMT2AMRGPRX4MAP2
SCHEMBL7885040 0.86 NEK2 (0.33) S1PR1NEK2PLK1MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed